ORIC Pharmaceuticals Inc

NASDAQ:ORIC   3:59:53 PM EDT
3.15
-0.11 (-3.37%)
Earnings Announcements

Oric Pharmaceuticals Reports Fourth Quarter Loss Per Share Of $0.58

Published: 03/21/2022 20:09 GMT
ORIC Pharmaceuticals Inc (ORIC) - Oric Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update.
Oric Pharmaceuticals Inc - Qtrly Loss per Share $0.58.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.60

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.61

More details on our Analysts Page.